INCRUSE.COM: Keyword Density Checker

Total words: 6435 | 2-word phrases: 1659 | 3-word phrases: 1990 | 4-word phrases: 2118

PAGE INFO

Title	Try to keep the title under 60 characters (49 characters) INCRUSE homepage \| INCRUSE ELLIPTA (umeclidinium)
Description	Try to keep the meta description between 50 - 160 characters (27 characters) Learn about INCRUSE ELLIPTA
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (89 characters) INCRUSE helps people with COPD breathe better for a full 24 hours. Your results may vary.

#	Keyword	Frequency	Density
1	do not use incruse	6	0.28%
2	have a rescue inhaler	6	0.28%
3	call your healthcare provider	6	0.28%
4	to relieve sudden breathing	6	0.28%
5	healthcare provider if you	6	0.28%
6	bronchitis emphysema or both	5	0.24%
7	with you to treat	5	0.24%
8	your healthcare provider if	5	0.24%
9	used long term to	5	0.24%
10	long term to treat	5	0.24%
11	oncedaily incruse is a	5	0.24%
12	if you have a	5	0.24%
13	you to treat sudden	5	0.24%
14	not used to relieve	4	0.19%
15	relieve sudden breathing problems	4	0.19%
16	is not used to	4	0.19%
17	a severe allergy to	4	0.19%
18	if you are not	4	0.19%
19	provider if you are	4	0.19%
20	incruse and call your	4	0.19%
21	incruse is not used	4	0.19%
22	replace a rescue inhaler	4	0.19%
23	ingredients in incruse ask	4	0.19%
24	to treat sudden symptoms	4	0.19%
25	you have a severe	4	0.19%
26	including chronic bronchitis emphysema	4	0.19%
27	term to treat chronic	4	0.19%
28	to treat chronic obstructive	4	0.19%
29	have a severe allergy	4	0.19%
30	right away if you	4	0.19%
31	incruse if you have	4	0.19%
32	chronic bronchitis emphysema or	4	0.19%
33	severe allergy to milk	4	0.19%
34	and call your healthcare	4	0.19%
35	flareups incruse is not	3	0.14%
36	if you have these	3	0.14%
37	fewer flareups incruse is	3	0.14%
38	the medicines you take	3	0.14%
39	used to relieve sudden	3	0.14%
40	right away before taking	3	0.14%

#	URL	Whois	Check
1	https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Incruse_Ellipta/pdf/INCRUSE-ELLIPTA-PI-PIL-IFU.PDF	Whois	gskpro.com
2	https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Incruse_Ellipta/pdf/INCRUSE-ELLIPTA-PI-PIL-IFU.PDF#nameddest=PIL	Whois	gskpro.com
3	https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Incruse_Ellipta/pdf/INCRUSE-ELLIPTA-PI-PIL-IFU.PDF	Whois	gskpro.com
4	https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Incruse_Ellipta/pdf/INCRUSE-ELLIPTA-PI-PIL-IFU.PDF#nameddest=PIL	Whois	gskpro.com
5	https://www.trelegy.com/copd/why-trelegy-for-copd/	Whois	trelegy.com
6	https://www.lung.org	Whois	lung.org
7	https://www.copdfoundation.org/	Whois	copdfoundation.org
8	http://www.emphysemafoundation.org/	Whois	emphysemafoundation.org
9	https://uscopdcoalition.org/	Whois	uscopdcoalition.org
10	http://www.fda.gov/medwatch	Whois	fda.gov
11	https://contactus.gsk.com/callback.html	Whois	gsk.com
12	https://www.gskforyou.com	Whois	gskforyou.com
13	https://www.gskforyou.com/	Whois	gskforyou.com
14	https://us.gsk.com/en-us/legal-notices/	Whois	gsk.com
15	https://privacy.gsk.com/en-us/privacy-notice/	Whois	gsk.com
16	https://privacy.gsk.com/en-us/privacy-notice/consumer-health-privacy	Whois	gsk.com
17	https://us.gsk.com/en-us/about-our-ads/	Whois	gsk.com
18	https://contactus.gsk.com/	Whois	gsk.com
19	https://www.gskforyou.com/	Whois	gskforyou.com
20	https://us.gsk.com/	Whois	gsk.com